Highlights Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Market Closed - Nyse Other stock markets 21:15:00 10/05/2024 BST			5-day change	1st Jan Change
279.9 ^USD	0.00%		0.00%	-12.71%

05-08	UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating	MT
05-08	RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	05-07	RE
Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline	05-07	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 Revenue $610.8M, vs. Street Est of $620.1M	05-07	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 EPS $2.29, vs. Street Est of $2.14	05-07	MT
Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	04-11	CI
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	03-25	MT
Bio Rad Labs rises after posting upbeat fourth-quarter profit	02-15	RE
Bio-Rad Laboratories Q4 Adjusted Earnings, Revenue Decline, Shares Rise After-Hours	02-15	MT
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Posts Q4 Revenue $681.2M, vs. Street Est of $686.6M	02-15	MT
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Reports Q4 EPS $3.10, vs. Street Est of $2.87	02-15	MT
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-15	CI
Slow start for Wall Street	01-03
Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	27/10/23	CI
Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending	26/10/23	RE
Bio-Rad Laboratories Q3 Non-GAAP Earnings, Sales Decline -- Shares Drop After Hours	26/10/23	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Posts Q3 EPS $2.33, vs. Street Est of $2.81	26/10/23	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Posts Q3 Revenue $632.1M, vs. Street Est of $691.7M	26/10/23	MT
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23	CI
Bio-Rad Laboratories' Q2 Non-GAAP Earnings, Revenue Fall	03/08/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Highlights

Filters